Jennifer Heeter
Nurse Practitioner · Tempe, AZNPI 1487114054
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 417 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,154 and has fallen 98.5% since, to $46 in 2024. Among nurse practitioner clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 417 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$843
- AbbVie$823
- Teva Pharmaceuticals USA, Inc.$651
- SK Life Science, Inc.$608
- Biohaven Pharmaceuticals, Inc.$542
- Biogen$456
- plus $4K from 30 others
What the payments were for
- Food & beverage$7,40796%
- Education$2854%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 55 | $843 |
| AbbVie(2 entities) | 63 | $823 |
| Teva Pharmaceuticals USA, Inc. | 35 | $651 |
| SK Life Science, Inc. | 24 | $608 |
| Biohaven Pharmaceuticals, Inc. | 10 | $542 |
| Biogen | 21 | $456 |
| Novartis | 36 | $422 |
| Sanofi | 19 | $325 |
| Amneal Pharmaceuticals LLC | 20 | $275 |
| Livanova USA, Inc. | 6 | $262 |
| Amgen(2 entities) | 15 | $243 |
| EMD Serono, Inc. | 7 | $222 |
| AstraZeneca | 11 | $198 |
| Acadia Pharmaceuticals Inc | 11 | $189 |
| Argenx US, Inc. | 7 | $182 |
| Neurelis, Inc. | 10 | $172 |
| Sunovion Pharmaceuticals Inc. | 11 | $162 |
| Neurocrine Biosciences, Inc. | 6 | $148 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Lilly USA, LLC | 9 | $121 |
| Corium, LLC | 7 | $89 |
| Tanabe Pharma America, Inc. | 4 | $87 |
| Genentech USA, Inc. | 4 | $74 |
| Pfizer | 4 | $71 |
| Eisai Inc. | 3 | $59 |
| Lundbeck LLC | 3 | $58 |
| Alnylam Pharmaceuticals Inc. | 4 | $56 |
| Microtransponder, Inc. | 1 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Johnson & Johnson | 2 | $30 |
| Alfasigma USA, Inc. | 1 | $24 |
| Smith+Nephew | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Impel Pharmaceuticals Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$236
- VNS Therapy$176
- REXULTI$125
- AUSTEDO$122
- QULIPTA$110
- UBRELVY$110
- Mavenclad$106
How this compares
$7,692 in reported general payments places this provider in the 95th percentile of 1,719 nurse practitioner providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 11 | $8,671 |
| Lacosamide | 27 | $5,576 |
| Carbamazepine ErCarbamazepine | 27 | $3,664 |
| Tiagabine Hcl | 12 | $2,788 |
| Divalproex Sodium ErDivalproex Sodium | 23 | $2,359 |
| Levetiracetam | 56 | $2,174 |
| Divalproex Sodium | 23 | $1,179 |
| Carbamazepine | 11 | $1,136 |
| Memantine Hcl | 21 | $1,062 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $823 |
| Donepezil Hcl | 26 | $810 |
| Gabapentin | 33 | $787 |
| Lamotrigine | 30 | $753 |
| Zonisamide | 16 | $596 |
| Ofloxacin | 12 | $472 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Tempe
- Ann MooreGlendale$208K
- Sandra KurtinTucson$201K
- Kristen HerzogScottsdale$162K
- Krista ArredondoChandler$133K
- Shannon MorgensternOro Valley$71K
- Helena In't VeldPhoenix$64K
- Steven KalfusChandler$43K
- Dustin NickersonPhoenix$39K
- Shannon BoffeliFlagstaff$31K
- Kelley RoneScottsdale$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.